Tag: Elixir Medical
EuroPCR 2026: DynamX bioadaptor demonstrates significantly lower event rates than drug-eluting stent
Elixir Medical has announ...
TCT 2024: Six-month data reflect safety and efficacy of Lithix HC-IVL system
Six-month data from t...
TCT 2024: Coronary bioadaptor shows clinical benefit in complex PCI sub-groups
Late-breaking data fr...
DynamX sirolimus-eluting bioadaptor system gains US FDA breakthrough designation
Elixir Medical has an...
TCT 2017: Elixir Medical to reveal “a game-changing metallic drug-eluting stent platform”
Elixir Medical has reveal...
TCT 2016: “Excellent” rates of late lumen loss with Desolve bioresorbable scaffold
Six-month clinical data f...
TCT 2016: First live case featuring Desolve NXT scaffold to be presented
Elixir Medical has announ...
